isotretinoin and Chromosome-Deletion

isotretinoin has been researched along with Chromosome-Deletion* in 2 studies

Other Studies

2 other study(ies) available for isotretinoin and Chromosome-Deletion

ArticleYear
Kansl1 haploinsufficiency impairs autophagosome-lysosome fusion and links autophagic dysfunction with Koolen-de Vries syndrome in mice.
    Nature communications, 2022, 02-17, Volume: 13, Issue:1

    Koolen-de Vries syndrome (KdVS) is a rare disorder caused by haploinsufficiency of KAT8 regulatory NSL complex subunit 1 (KANSL1), which is characterized by intellectual disability, heart failure, hypotonia, and congenital malformations. To date, no effective treatment has been found for KdVS, largely due to its unknown pathogenesis. Using siRNA screening, we identified KANSL1 as an essential gene for autophagy. Mechanistic study shows that KANSL1 modulates autophagosome-lysosome fusion for cargo degradation via transcriptional regulation of autophagosomal gene, STX17. Kansl1

    Topics: Abnormalities, Multiple; Animals; Autophagosomes; Cerebral Cortex; Chromosome Deletion; Chromosomes, Human, Pair 17; Disease Models, Animal; Female; Haploinsufficiency; HeLa Cells; Humans; Intellectual Disability; Isotretinoin; Lysosomes; Mice; Mice, Transgenic; Mitophagy; Neurons; Nuclear Proteins; Primary Cell Culture

2022
A Case of Myelofibrosis and Myelodysplasia Identified Following Exposure to Isotretinoin.
    Journal of pediatric hematology/oncology, 2021, Volume: 43, Issue:1

    A 15-year-old male individual treated with isotretinoin for acne vulgaris presented with persistent pancytopenia and circulating myeloblasts after discontinuation of the drug. Marrow assessment revealed myelofibrosis (MF) and myeloblasts exhibiting monosomy 7, diagnostic of myelodysplastic syndrome (MDS). Although a popular website seems to associate isotretinoin with MF, no published cases of MF or MDS attributable to this drug were identified. Although we expect that he would eventually have developed MDS and MF, this patient was perhaps identified sooner due to cytopenias accelerated by isotretinoin. This case illustrates that patients exhibiting cytopenias persisting following isotretinoin therapy merit evaluation for underlying hematopoietic disorders.

    Topics: Acne Vulgaris; Adolescent; Chromosome Deletion; Chromosomes, Human, Pair 7; Dermatologic Agents; Humans; Isotretinoin; Male; Myelodysplastic Syndromes; Pancytopenia; Primary Myelofibrosis; Prognosis

2021